The importance of AI for Biopharma, in the view of Alexion (AstraZeneca’s rare disease unit), and how the company is using it.
My Account
Learn more about Global Insights at Citi
Subscribe
Sign up to receive our newsletter providing a roundup of recent content and updates on new reports.
Sign up to receive the latest news from Citi.
